Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dystrophinopathies]

P Gallano1, A Lasa, M Baiget

  • 1Unidad de Genética Molecular, Hospital de la Santa Creu i Sant Pau, Barcelona.

Neurologia (Barcelona, Spain)
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Effectiveness of a nutrition education programme for individuals with celiac disease and their supporters through social media (GLUTLEARN project)' Comput. Biol. Med. 184 (2025) 109505.

Computers in biology and medicine·2026
Same author

Novel DES mutation presenting with isolated restrictive respiratory failure. Expanding the clinical spectrum.

Neurologia·2025
Same author

Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: a comparison with its analog resveratrol.

Food & function·2021
Same author

Insight into the microbial communities associated with first larval stages of Mytilus galloprovincialis: Possible interference by estrogenic compounds.

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP·2020
Same author

<i>In vitro</i> approach for evaluation of carob by-products as source bioactive ingredients with potential to attenuate metabolic syndrome (MetS).

Heliyon·2019
Same author

Gluten-free-rendered products contribute to imbalanced diets in children and adolescents with celiac disease.

European journal of nutrition·2018
Same journal

[Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine].

Neurologia (Barcelona, Spain)·2024
Same journal

[SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis].

Neurologia (Barcelona, Spain)·2024
Same journal

[Bell's palsy following COVID-19 vaccination: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Parsonage-Turner syndrome post-infection by SARS-CoV-2: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Acute transverse myelitis following SARS-CoV-2 infection].

Neurologia (Barcelona, Spain)·2024
Same journal

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024
See all related articles

The identification of dystrophin revolutionized the understanding of X-linked muscular dystrophies, now termed dystrophinopathies. Genetic analysis, including DNA examination, enabled precise diagnosis and characterization of these conditions.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Context:

  • X-linked muscular dystrophies were previously grouped under Duchenne's (DMD) and Becker's (BMD) muscular dystrophies.
  • The identification of dystrophin, a cytoskeletal protein, in 1987 marked a paradigm shift.
  • Advancements in polymerase chain reaction and reverse genetics facilitated DNA examination.

Purpose:

  • To reclassify X-linked muscular dystrophies as dystrophinopathies based on dystrophin identification.
  • To extend genetic studies of dystrophinopathies in the 1990s.
  • To enable molecular-level diagnosis of atypical phenotypes.

Summary:

  • Dystrophin, a key cytoskeletal protein, was identified in 1987, leading to the concept of dystrophinopathies.
  • The DMD/BMD gene was located, sequenced, and its protein product, dystrophin, fully identified.

Related Experiment Videos

  • Genetic studies in the 1990s focused on DNA analysis to discover mutations, understand protein translation, and diagnose phenotypes.

    • Impact:

    • Established a new conceptual framework for X-linked muscular dystrophies (dystrophinopathies).
    • Enabled precise molecular diagnosis of muscular dystrophies using DNA analysis and anti-dystrophin antibodies.
    • Advanced the understanding of genetic mutations and protein translation in Xp21 myopathies.